The PuMP Trial: "A Multistage Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 in Patients with Recurrent High-Grade Glioma"
Clinical Trial Grant
Awarded By
ImmVira Co., Limited
Start Date
August 6, 2026
End Date
August 16, 2031
Awarded By
ImmVira Co., Limited
Start Date
August 6, 2026
End Date
August 16, 2031